Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Vertex Pharmaceuticals Inc Transaction History
Empirical Financial Services, LLC D.B.A. Empirical Wealth Management
- $4.37 Billion
- Q2 2025
A detailed history of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Empirical Financial Services, LLC D.B.A. Empirical Wealth Management holds 2,052 shares of VRTX stock, worth $963,721. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,052
Previous 1,837
11.7%
Holding current value
$963,721
Previous $890,000
2.58%
% of portfolio
0.02%
Previous 0.02%
Shares
17 transactions
Others Institutions Holding VRTX
# of Institutions
1,827Shares Held
231MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$13.4 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$11 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.83 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.54 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $121B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...